Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
J Cell Biol ; 208(1): 23-32, 2015 01 05.
Article in English | MEDLINE | ID: mdl-25559184

ABSTRACT

The role of the RhoGTPase Rac1 in stabilizing mature endothelial adherens junctions (AJs) is not well understood. In this paper, using a photoactivatable probe to control Rac1 activity at AJs, we addressed the relationship between Rac1 and the dynamics of vascular endothelial cadherin (VE-cadherin). We demonstrated that Rac1 activation reduced the rate of VE-cadherin dissociation, leading to increased density of VE-cadherin at AJs. This response was coupled to a reduction in actomyosin-dependent tension across VE-cadherin adhesion sites. We observed that inhibiting myosin II directly or through photo-release of the caged Rho kinase inhibitor also reduced the rate of VE-cadherin dissociation. Thus, Rac1 functions by stabilizing VE-cadherin trans-dimers in mature AJs by counteracting the actomyosin tension. The results suggest a new model of VE-cadherin adhesive interaction mediated by Rac1-induced reduction of mechanical tension at AJs, resulting in the stabilization of VE-cadherin adhesions.


Subject(s)
Adherens Junctions/enzymology , Antigens, CD/metabolism , Cadherins/metabolism , Endothelial Cells/enzymology , rac1 GTP-Binding Protein/metabolism , Actomyosin/metabolism , Adherens Junctions/drug effects , Antigens, CD/genetics , Cadherins/genetics , Cell Adhesion , Cells, Cultured , Endothelial Cells/drug effects , Enzyme Activation , Humans , Kinetics , Microscopy, Fluorescence , Microscopy, Video , Models, Biological , Myosin Type II/metabolism , Protein Binding , Protein Kinase Inhibitors/pharmacology , Protein Multimerization , Protein Stability , Time-Lapse Imaging , Transfection , rac1 GTP-Binding Protein/genetics , rho-Associated Kinases/antagonists & inhibitors , rho-Associated Kinases/metabolism
3.
Mol Cell ; 48(6): 914-25, 2012 Dec 28.
Article in English | MEDLINE | ID: mdl-23159740

ABSTRACT

Vascular endothelial (VE)-cadherin homophilic adhesion controls endothelial barrier permeability through assembly of adherens junctions (AJs). We observed that loss of VE-cadherin-mediated adhesion induced the activation of Src and phospholipase C (PLC)γ2, which mediated Ca(2+) release from endoplasmic reticulum (ER) stores, resulting in activation of calcineurin (CaN), a Ca(2+)-dependent phosphatase. Downregulation of CaN activity induced phosphorylation of serine 162 in end binding (EB) protein 3. This phospho-switch was required to destabilize the EB3 dimer, suppress microtubule (MT) growth, and assemble AJs. The phospho-defective S162A EB3 mutant, in contrast, induced MT growth in confluent endothelial monolayers and disassembled AJs. Thus, VE-cadherin outside-in signaling regulates cytosolic Ca(2+) homeostasis and EB3 phosphorylation, which are required for assembly of AJs. These results identify a pivotal function of VE-cadherin homophilic interaction in modulating endothelial barrier through the tuning of MT dynamics.


Subject(s)
Adherens Junctions/metabolism , Antigens, CD/physiology , Cadherins/physiology , Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Protein Processing, Post-Translational , Antigens, CD/metabolism , Cadherins/metabolism , Calcineurin/metabolism , Calcium/metabolism , Calcium Signaling , Calmodulin/metabolism , Cell Adhesion , Cells, Cultured , Endothelial Cells/enzymology , Endothelial Cells/metabolism , Endothelium, Vascular/cytology , Enzyme Activation , Homeostasis , Humans , Kinetics , Microscopy, Confocal , Phospholipase C gamma/metabolism , Phosphorylation , Protein Binding , Time-Lapse Imaging , src-Family Kinases/metabolism
4.
J Transl Med ; 9: 101, 2011 Jul 02.
Article in English | MEDLINE | ID: mdl-21722394

ABSTRACT

BACKGROUND: Non Obese Diabetic mice lacking B cells (NOD.Igµ(null) mice) do not develop diabetes despite their susceptible background. Upon reconstitution of B cells using a chimera approach, animals start developing diabetes at 20 weeks of age. METHODS: We have used the spectratyping technique to follow the T cell receptor (TCR) V beta repertoire of NOD.Igµ(null) mice following B cell reconstitution. This technique provides an unbiased approach to understand the kinetics of TCR expansion. We have also analyzed the TCR repertoire of reconstituted animals receiving cyclophosphamide treatment and following tissue transplants to identify common aggressive clonotypes. RESULTS: We found that B cell reconstitution of NOD.Igµ(null) mice induces a polyclonal TCR repertoire in the pancreas 10 weeks later, gradually diversifying to encompass most BV families. Interestingly, these clonotypic BV expansions are mainly confined to the pancreas and are absent from pancreatic lymph nodes or spleens. Cyclophosphamide-induced diabetes at 10 weeks post-B cell reconstitution reorganized the predominant TCR repertoires by removing potential regulatory clonotypes (BV1, BV8 and BV11) and increasing the frequency of others (BV4, BV5S2, BV9, BV16-20). These same clonotypes are more frequently present in neonatal pancreatic transplants under the kidney capsule of B-cell reconstituted diabetic NOD.Igµ(null) mice, suggesting their higher invasiveness. Phenotypic analysis of the pancreas-infiltrating lymphocytes during diabetes onset in B cell reconstituted animals show a predominance of CD19+ B cells with a B:T lymphocyte ratio of 4:1. In contrast, in other lymphoid organs (pancreatic lymph nodes and spleens) analyzed by FACS, the B:T ratio was 1:1. Lymphocytes infiltrating the pancreas secrete large amounts of IL-6 and are of Th1 phenotype after CD3-CD28 stimulation in vitro. CONCLUSIONS: Diabetes in NOD.Igµ(null) mice appears to be caused by a polyclonal repertoire of T cell accumulation in pancreas without much lymphoid organ involvement and is dependent on the help by B cells.


Subject(s)
B-Lymphocytes/immunology , Diabetes Mellitus, Experimental/immunology , Immunoglobulin mu-Chains/immunology , Immunophenotyping/methods , Islets of Langerhans/immunology , T-Lymphocytes/immunology , Animals , Animals, Newborn , B-Lymphocytes/cytology , Cell Proliferation , Clone Cells , Cyclophosphamide , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/pathology , Graft Rejection/complications , Graft Rejection/immunology , Graft Rejection/pathology , Immunologic Memory/immunology , Islets of Langerhans/pathology , Islets of Langerhans Transplantation , Mice , Mice, Inbred NOD , Phenotype , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Spleen/pathology , T-Lymphocytes/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...